Patents by Inventor Liraz Levi

Liraz Levi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230150931
    Abstract: Disclosed herein are FABP4 and FABP5 inhibitor compounds and their use in pharmaceutical compositions for treating diseases relating to fatty acid metabolism, including cancer. Also disclosed herein are methods for preparing the disclosed compounds.
    Type: Application
    Filed: September 14, 2022
    Publication date: May 18, 2023
    Applicant: Novius Therapeutics, LLC
    Inventors: Liraz Levi, Tej Pareek, Elizabeth Meyers, Seunghwan Lim, William J. Greenlee, Seong-Jin Kim
  • Publication number: 20230132140
    Abstract: The present application discloses a method of treating cancer, including administering to a person suffering from cancer or in remission from cancer, an antigen presenting cell loaded with an immunogenic CD4 T cell activating antigen and a CD8 T cell activating neoantigen specific for the cancer.
    Type: Application
    Filed: September 15, 2022
    Publication date: April 27, 2023
    Applicant: Celloram Inc.
    Inventors: Seunghwan Lim, Tej Kumar Pareek, Liraz Levi, Seong-Jin Kim